Inequities in colorectal and breast cancer screening: At the intersection of race/ethnicity, sexuality, and gender by Emmeline Lin, Patrycja Sleboda, Bobbie J. Rimel, Geetanjali D. Datta

Get full text

Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer. by Christine S Walsh, Mitchell Kamrava, Andre Rogatko, Sungjin Kim, Andrew Li, Ilana Cass, Beth Karlan, Bobbie J Rimel

Get full text

Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphos... by Bobbie J. Rimel, Dana M. Chase, Jessica Perhanidis, Armen A. Ghazarian, Ella Xiaoyan Du, Travis Wang, Jinlin Song, Amanda K. Golembesky, Jean A. Hurteau, Linda Kalilani, Ritu Salani, Bradley J. Monk

Get full text

Ovarian Transposition Before Pelvic Radiation Therapy: Spatial Distribution and Dose Volume Analysis by Christopher Gay, MD, Yaniv R. Raphael, MD, Jennifer Steers, PhD, Diana J. Lu, MD, John H. Lewis, PhD, John DeMarco, PhD, Benedick Fraass, PhD, Bobbie J. Rimel, MD, Roja Zakariaee, PhD, Mitchell Kamrava, MD, Katelyn M. Atkins, MD, PhD

Get full text

DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers by Nicole Gull, Michelle R. Jones, Pei-Chen Peng, Simon G. Coetzee, Tiago C. Silva, Jasmine T. Plummer, Alberto Luiz P. Reyes, Brian D. Davis, Stephanie S. Chen, Kate Lawrenson, Jenny Lester, Christine Walsh, Bobbie J. Rimel, Andrew J. Li, Ilana Cass, Yonatan Berg, John-Paul B. Govindavari, Joanna K. L. Rutgers, Benjamin P. Berman, Beth Y. Karlan, Simon A. Gayther

Get full text